Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$40.65 - $65.76 $63,129 - $102,125
-1,553 Reduced 24.78%
4,714 $226,000
Q4 2023

Feb 13, 2024

BUY
$48.3 - $68.06 $45,160 - $63,636
935 Added 17.54%
6,267 $406,000
Q2 2023

Aug 01, 2023

BUY
$56.23 - $71.17 $25,753 - $32,595
458 Added 9.4%
5,332 $310,000
Q1 2023

May 10, 2023

BUY
$53.43 - $68.12 $54,124 - $69,005
1,013 Added 26.24%
4,874 $300,000
Q4 2022

Jan 31, 2023

BUY
$61.23 - $83.62 $17,450 - $23,831
285 Added 7.97%
3,861 $245,000
Q3 2022

Oct 27, 2022

SELL
$65.58 - $84.69 $74,433 - $96,123
-1,135 Reduced 24.09%
3,576 $260,000
Q2 2022

Aug 08, 2022

BUY
$52.13 - $93.81 $245,584 - $441,938
4,711 New
4,711 $320,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.